Instrument Inactif

Communiqués Transition Therapeutics Inc

Actions

TTH

CA8937162094

Produits pharmaceutiques

Communiqués

26/08/16	Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	PR
03/06/16	Transition Therapeutics : Receives Notification From NASDAQ	PR
11/05/16	Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	PR
09/05/16	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	PR
18/04/16	Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	PR
17/03/16	Transition Therapeutics : Receives Notification From NASDAQ	PR
01/03/16	Transition Therapeutics : to Present at the 36th Annual Cowen Healthcare Conference	PR
09/02/16	Transition Therapeutics : Announces Second Quarter Fiscal 2016 Financial Results	PR
05/02/16	Transition Therapeutics : to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST	PR
01/02/16	Transition Therapeutics : Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401	PR
06/01/16	Transition Therapeutics : Announces Annual General Meeting Voting Results	PR
19/11/15	Transition Therapeutics : to Host Investor Day November 23 in New York	PR
10/11/15	Transition Therapeutics : Announces First Quarter Fiscal 2016 Financial Results	PR
02/11/15	Transition Therapeutics : to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST	PR
28/10/15	Transition Therapeutics : Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's Disease (CTAD) Conference	PR
15/10/15	Transition Therapeutics : Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression in Alzheimer's Disease Patients	PR
15/09/15	Transition Therapeutics : Announces Fiscal 2015 Financial Results	PR
14/09/15	Transition Therapeutics : to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST	PR
10/08/15	Transition Therapeutics : to Present at the Canaccord Genuity 35th Annual Growth Conference	PR
24/06/15	Transition Therapeutics : Announces Results of Clinical Study of ELND005 in Agitation and Aggression in Patients with Alzheimer's Disease	PR
16/06/15	Transition Therapeutics : Appoints Carl Damiani as President	PR
26/05/15	Transition Therapeutics : to Present at the Jefferies 2015 Healthcare Conference	PR
12/05/15	Transition Therapeutics : Announces Third Quarter Fiscal 2015 Financial Results	PR
07/05/15	Transition Therapeutics : to Hold Conference Call on Third Quarter Fiscal 2015 Financial Results on Tuesday, May 12th, at 4:30 P.M. EST	PR
06/05/15	Transition Therapeutics : In-Licenses Phase 2 Drug Candidate from Lilly	PR